Milipitas, CA-based Bigfoot Biomedical Inc. announced on 2 June it closed a $55m series C financing, which was led by Abbott Laboratories Inc. with support from existing investors including Quadrant Capital Advisors, Senvest Capital, Janus Henderson and Cormorant Asset Management and new investors including the Smile Group.
The company said it will use the proceeds from the financing to complete the product development and file for US...







